Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia
The DOI matches its Crossref record; 83 of the 84 references it cites were found in a registry or an index.
Abstract
Abnormal expression of the N-methyl-D-Aspartate (NMDA) receptor and its interacting molecules of the postsynaptic density (PSD) are thought to be involved in the pathophysiology of schizophrenia. Frontal regions of neocortex including dorsolateral prefrontal (DLPFC) and anterior cingulate cortex (ACC) are essential for cognitive and behavioral functions that are affected in schizophrenia. In this study, we have measured protein expression of two alternatively spliced isoforms of the NR1 subunit (NR1C2 and NR1C2') as well as expression of the NR2A-D subunits of the NMDA receptor in DLPFC and ACC in post-mortem samples from elderly schizophrenic patients and a comparison group. We found significantly increased expression of NR1C2' but not of NR1C2 in ACC, suggesting altered NMDA receptor cell membrane expression in this cortical area. We did not find significant changes in the expression of either of the NR1 isoforms in DLPFC. We did not detect changes of any of the NR2 subunits studied in either cortical area. In addition, we studied expression of the NMDA-interacting PSD molecules NF-L, SAP102, PSD-95 and PSD-93 in ACC and DLPFC at both transcriptional and translational levels. We found significant changes in the expression of NF-L in DLPFC, and PSD-95 and PSD-93 in ACC; increased transcript expression was associated with decreased protein expression, suggesting abnormal translation and/or accelerated protein degradation of these molecules in schizophrenia. Our findings suggest abnormal regional processing of the NMDA receptor and its associated PSD molecules, possibly involving transcription, translation, trafficking and protein stability in cortical areas in schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, PSD-95 protein levels are reduced in the schizophrenia cortex59.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [59]
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
MacDonald, A. W., Cohen, J. D., Stenger, V. A., & Carter, C. S. (2000) · Science · doi:10.1126/science.288.5472.1835 · Cited by 3,666
Anterior Cingulate Conflict Monitoring and Adjustments in Control
Kerns, J. G., Cohen, J. D., MacDonald, A. W., Cho, R. Y., Stenger, V. A., & Carter, C. S. (2004) · Science · doi:10.1126/science.1089910 · Cited by 2,891
Domain Interaction Between NMDA Receptor Subunits and the Postsynaptic Density Protein PSD-95
Kornau, H.-C., Schenker, L. T., Kennedy, M. B., & Seeburg, P. H. (1995) · Science · doi:10.1126/science.7569905 · Cited by 1,904
NMDA receptor subunits: diversity, development and disease
Cull-Candy, S., Brickley, S., & Farrant, M. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00215-4 · Cited by 1,694
NMDA receptor hypofunction model of schizophrenia
Olney, J. W., Newcomer, J. W., & Farber, N. B. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00029-1 · Cited by 1,020
The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia
Goff, D. C., & Coyle, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1367 · Cited by 915
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M., & Gogos, J. A. (2004) · Nature Genetics · doi:10.1038/ng1296 · Cited by 913
Niethammer, M., Kim, E., & Sheng, M. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02157.1996 · Cited by 750
Kinesin Superfamily Motor Protein KIF17 and mLin-10 in NMDA Receptor-Containing Vesicle Transport
Setou, M., Nakagawa, T., Seog, D.-H., & Hirokawa, N. (2000) · Science · doi:10.1126/science.288.5472.1796 · Cited by 708
Cited by
Dendritic spine pathology in neuropsychiatric disorders
Penzes, P., Cahill, M. E., Jones, K. A., VanLeeuwen, J.-E., & Woolfrey, K. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2741 · Cited by 1,523
Gao, R., & Penzes, P. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150303003028 · Cited by 516
Schizophrenia is associated with an increase in cortical microRNA biogenesis
Beveridge, N. J., Gardiner, E., Carroll, A. P., Tooney, P. A., & Cairns, M. J. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.84 · Cited by 432
Beneyto, M., Kristiansen, L. V., Oni-Orisan, A., McCullumsmith, R. E., & Meador-Woodruff, J. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301312 · Cited by 408
Self-citationGlutamate hypothesis in schizophrenia
Uno, Y., & Coyle, J. T. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12823 · Cited by 367
Prefrontal Cortical Dendritic Spine Pathology in Schizophrenia and Bipolar Disorder
Konopaske, G. T., Lange, N., Coyle, J. T., & Benes, F. M. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1582 · Cited by 379
Neuroplasticity of Neocortical Circuits in Schizophrenia
Lewis, D. A., & González-Burgos, G. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301563 · Cited by 365
PSD95: A synaptic protein implicated in schizophrenia or autism?
Coley, A. A., & Gao, W.-J. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.016 · Cited by 359
The Neuregulin-1 Receptor ErbB4 Controls Glutamatergic Synapse Maturation and Plasticity
Li, B., Woo, R.-S., Mei, L., & Malinow, R. (2007) · Neuron · doi:10.1016/j.neuron.2007.03.028 · Cited by 354
Neurofilaments: neurobiological foundations for biomarker applications
Gafson, A. R., Barthélemy, N. R., Bomont, P., Carare, R. O., Durham, H. D., Julien, J.-P., Kuhle, J., Leppert, D., Nixon, R. A., Weller, R. O., et al. (2020) · Brain · doi:10.1093/brain/awaa098 · Cited by 325
Pathophysiologically based treatment interventions in schizophrenia
Lewis, D. A., & Gonzalez-Burgos, G. (2006) · Nature Medicine · doi:10.1038/nm1478 · Cited by 323
The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies
Hu, W., MacDonald, M. L., Elswick, D. E., & Sweet, R. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12547 · Cited by 286
Osimo, E. F., Beck, K., Reis Marques, T., & Howes, O. D. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0041-5 · Cited by 268
NMDA hypofunction as a convergence point for progression and symptoms of schizophrenia
Snyder, M. A., & Gao, W.-J. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00031 · Cited by 236
NMDA receptors and schizophrenia
KRISTIANSEN, L., HUERTA, I., BENEYTO, M., & MEADORWOODRUFF, J. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.013 · Cited by 246
Self-citationMolecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
Weickert, C. S., Fung, S. J., Catts, V. S., Schofield, P. R., Allen, K. M., Moore, L. T., Newell, K. A., Pellen, D., Huang, X.-F., Catts, S. V., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.137 · Cited by 236
Lewis, D. A., & Sweet, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37335 · Cited by 233
The DLGAP family: neuronal expression, function and role in brain disorders
Rasmussen, A. H., Rasmussen, H. B., & Silahtaroglu, A. (2017) · Molecular Brain · doi:10.1186/s13041-017-0324-9 · Cited by 234
Pennington, K., Beasley, C. L., Dicker, P., Fagan, A., English, J., Pariante, C. M., Wait, R., Dunn, M. J., & Cotter, D. R. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002098 · Cited by 227
Rethinking schizophrenia in the context of normal neurodevelopment
Catts, V. S., Fung, S. J., Long, L. E., Joshi, D., Vercammen, A., Allen, K. M., Fillman, S. G., Rothmond, D. A., Sinclair, D., Tiwari, Y., et al. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00060 · Cited by 206
Cell Type-Specific Development of NMDA Receptors in the Interneurons of Rat Prefrontal Cortex
Wang, H.-X., & Gao, W.-J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.20 · Cited by 203
Glutamatergic Synaptic Dysregulation in Schizophrenia: Therapeutic Implications
Coyle, J. T., Basu, A., Benneyworth, M., Balu, D., & Konopaske, G. (2012) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-25758-2_10 · Cited by 180
“…NMDA, AMPA, and kainate receptor subunits in the thalamus (Ibrahim et al. 2000) as well as PSD-95, SAP102, and NF-L; PSD-95 and NF-L were reduced in the anterior cingulate cortex (Kristiansen and MeadorWoodruff 2005; Kristiansen et al. 2006), the latter which is also affected in bipolar disorder.”
BackgroundKim, I. H., Racz, B., Wang, H., Burianek, L., Weinberg, R., Yasuda, R., Wetsel, W. C., & Soderling, S. H. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.0035-13.2013 · Cited by 172
PSD-95-like membrane associated guanylate kinases (PSD-MAGUKs) and synaptic plasticity
Xu, W. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.03.001 · Cited by 171
“Among the family members, expression of PSD-95 and PSD-93 has been shown to be dysregulated in neuropsychiatric patients [4], and loss of function mutations in the SAP102 gene cause nonsyndromic X-linked mental retardation [5].”
The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia
Håvik, B., Le Hellard, S., Rietschel, M., Lybæk, H., Djurovic, S., Mattheisen, M., Mühleisen, T. W., Degenhardt, F., Priebe, L., Maier, W., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.030 · Cited by 168
Catts, V. S., Lai, Y. L., Weickert, C. S., Weickert, T. W., & Catts, S. V. (2016) · Biological Psychology · doi:10.1016/j.biopsycho.2015.10.013 · Cited by 151
Funk, A. J., McCullumsmith, R. E., Haroutunian, V. H., & Meador‐Woodruff, J. H. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.267 · Cited by 174
Self-citationDendritic spine dynamics--a key role for kalirin-7
Penzes, P., & Jones, K. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.06.001 · Cited by 157
Berdenis van Berlekom, A., Muflihah, C. H., Snijders, G. J. L. J., MacGillavry, H. D., Middeldorp, J., Hol, E. M., Kahn, R. S., & de Witte, L. D. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz060 · Cited by 149
Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression
Karolewicz, B., Szebeni, K., Gilmore, T., Maciag, D., Stockmeier, C. A., & Ordway, G. A. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708008985 · Cited by 143
2‐D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease
English, J. A., Dicker, P., Föcking, M., Dunn, M. J., & Cotter, D. R. (2009) · PROTEOMICS · doi:10.1002/pmic.200900015 · Cited by 144
Forsyth, J. K., & Lewis, D. A. (2017) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2017.06.006 · Cited by 144
de Bartolomeis, A., Latte, G., Tomasetti, C., & Iasevoli, F. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8534-3 · Cited by 137
Steffek, A. E., McCullumsmith, R. E., Haroutunian, V. H., & Meador‐Woodruff, J. H. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.04.032 · Cited by 143
Self-citationContributions of the d-serine pathway to schizophrenia
Labrie, V., Wong, A. H. C., & Roder, J. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.030 · Cited by 128
Guo, X., Hamilton, P. J., Reish, N. J., Sweatt, J. D., Miller, C. A., & Rumbaugh, G. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.223 · Cited by 120
“In support of this idea, various PSD proteins, including PSD-95, are disrupted in the brains of schizophrenia patients (Kristiansen et al, 2006).”
Postmortem Brain: An Underutilized Substrate for Studying Severe Mental Illness
McCullumsmith, R. E., Hammond, J. H., Shan, D., & Meador-Woodruff, J. H. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.239 · Cited by 111
Self-citationDevelopmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex
Henson, M. A., Roberts, A. C., Salimi, K., Vadlamudi, S., Hamer, R. M., Gilmore, J. H., Jarskog, L. F., & Philpot, B. D. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn017 · Cited by 110
“As such, antibodies or approaches may exist that are better suited for detecting NR2A and NR2B levels in tissue with long PMIs (see Murphy et al. 2005; Kristiansen et al. 2006).”
BackgroundResultInfluentialTing, J. T., Peça, J., & Feng, G. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150442 · Cited by 108
Leuba, G., Savioz, A., Vernay, A., Carnal, B., Kraftsik, R., Tardif, E., Riederer, I., & Riederer, B. M. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-15112 · Cited by 103
Errico, F., Napolitano, F., Squillace, M., Vitucci, D., Blasi, G., de Bartolomeis, A., Bertolino, A., D’Aniello, A., & Usiello, A. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.06.013 · Cited by 112
Lecourtier, L., Homayoun, H., Tamagnan, G. D., & Moghaddam, B. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.12.003 · Cited by 111
Altered Vesicular Glutamate Transporter Expression in the Anterior Cingulate Cortex in Schizophrenia
Oni-Orisan, A., Kristiansen, L. V., Haroutunian, V. H., Meador‐Woodruff, J. H., & McCullumsmith, R. E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.020 · Cited by 107
Self-citationMolecular evidence of synaptic pathology in the CA1 region in schizophrenia
Matosin, N., Fernandez-Enright, F., Lum, J. S., Engel, M., Andrews, J. L., Gassen, N. C., Wagner, K. V., Schmidt, M. V., & Newell, K. A. (2016) · npj Schizophrenia · doi:10.1038/npjschz.2016.22 · Cited by 92
Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
Caruso, G., Grasso, M., Fidilio, A., Tascedda, F., Drago, F., & Caraci, F. (2020) · Pharmaceuticals · doi:10.3390/ph13120457 · Cited by 87
Renard, J., Vitalis, T., Rame, M., Krebs, M., Lenkei, Z., Pen, G. L., & Jay, T. M. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.11.005 · Cited by 95
Glutamate Receptor Abnormalities in Schizophrenia: Implications for Innovative Treatments
Rubio, M. D., Drummond, J. B., & Meador-Woodruff, J. H. (2012) · Biomolecules and Therapeutics · doi:10.4062/biomolther.2012.20.1.001 · Cited by 83
Self-citationFunk, A. J., Rumbaugh, G., Harotunian, V., McCullumsmith, R. E., & Meador-Woodruff, J. H. (2009) · NeuroReport · doi:10.1097/wnr.0b013e32832d30d9 · Cited by 85
Self-citationSpecialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders
Yuan, A., & Nixon, R. A. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.09.002 · Cited by 85
Kristiansen, L. V., Patel, S. A., Haroutunian, V., & Meador‐Woodruff, J. H. (2010) · Synapse · doi:10.1002/syn.20754 · Cited by 86
Self-citationLi, W., Ghose, S., Gleason, K., Begovic, A., Perez, J., Bartko, J., Russo, S., Wagner, A. D., Selemon, L., & Tamminga, C. A. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010123 · Cited by 84
Synaptic Dysfunction in Schizophrenia
Yin, D., Chen, Y., Sathyamurthy, A., Xiong, W., & Mei, L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_22 · Cited by 100
Xi, D., Zhang, W., Wang, H.-X., Stradtman, G. G., & Gao, W.-J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570900042x · Cited by 83
Leuba, G., Walzer, C., Vernay, A., Carnal, B., Kraftsik, R., Piotton, F., Marin, P., Bouras, C., & Savioz, A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.02.012 · Cited by 89
VCP and ATL1 regulate endoplasmic reticulum and protein synthesis for dendritic spine formation
Shih, Y.-T., & Hsueh, Y.-P. (2016) · Nature Communications · doi:10.1038/ncomms11020 · Cited by 82
Prini, P., Rusconi, F., Zamberletti, E., Gabaglio, M., Penna, F., Fasano, M., Battaglioli, E., Parolaro, D., & Rubino, T. (2018) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170082 · Cited by 80
McCullumsmith, R. E., & Meador‐Woodruff, J. H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.035 · Cited by 87
Self-citationSchizophrenia‐related endophenotypes in heterozygous neuregulin‐1 ‘knockout’ mice
O’Tuathaigh, C. M. P., Harte, M., O’Leary, C., O'Sullivan, G., Blau, C., Lai, D., Harvey, R. P., Tighe, O., Fagan, A. J., Kerskens, C., et al. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07069.x · Cited by 85
Downregulated AKT-mTOR signaling pathway proteins in dorsolateral prefrontal cortex in Schizophrenia
Chadha, R., & Meador‐Woodruff, J. H. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0614-2 · Cited by 79
Self-citationSnigdha, S., & Neill, J. C. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.10.012 · Cited by 74
Matosin, N., Fernandez-Enright, F., Frank, E., Deng, C., Wong, J., Huang, X.-F., & Newell, K. A. (2014) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.130242 · Cited by 73
Erben, L., He, M., Laeremans, A., Park, E., & Buonanno, A. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0834-6 · Cited by 77
Ruzicka, B., Mohammadi, S., Dávila-Velderrain, J., Subburaju, S., Tso, D. R., Hourihan, M., & Kellis, M. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.02.273 · Cited by 73
Xing, J., Kimura, H., Wang, C., Ishizuka, K., Kushima, I., Arioka, Y., Yoshimi, A., Nakamura, Y., Shiino, T., Oya‐Ito, T., et al. (2016) · Scientific Reports · doi:10.1038/srep27491 · Cited by 76
Xi, D., Keeler, B., Zhang, W., Houle, J. D., & Gao, W.-J. (2009) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2008.09.013 · Cited by 66
Stewart, L. R., Hall, A. L., Kang, S.-H. L., Shaw, C. A., & Beaudet, A. L. (2011) · BMC Medical Genetics · doi:10.1186/1471-2350-12-154 · Cited by 64
Fumagalli, F., Frasca, A., Racagni, G., & Riva, M. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.043786 · Cited by 69
The first decade and beyond of transcriptional profiling in schizophrenia
Sequeira, P. A., Martin, M. V., & Vawter, M. P. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.03.001 · Cited by 64
Evidence for Shared Genetic Risk Between Methamphetamine-Induced Psychosis and Schizophrenia
Ikeda, M., Okahisa, Y., Aleksić, B., Won, M., Kondo, N., Naruse, N., Aoyama‐Uehara, K., Sora, I., Iyo, M., Hashimoto, R., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.94 · Cited by 67
The Communication Between the Immune and Nervous Systems: The Role of IL-1β in Synaptopathies
Pozzi, D., Menna, E., Canzi, A., Desiato, G., Mantovani, C., & Matteoli, M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00111 · Cited by 68
Soler, J., Fañanás, L., Parellada, M., Krebs, M., Rouleau, G. A., & Fatjó‐Vilas, M. (2018) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170066 · Cited by 71
Dysfunctional gene splicing as a potential contributor to neuropsychiatric disorders
Glatt, S. J., Cohen, O. S., Faraone, S. V., & Tsuang, M. T. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31181 · Cited by 63
Catts, V. S., Derminio, D. S., Hahn, C.-G., & Weickert, C. S. (2015) · npj Schizophrenia · doi:10.1038/npjschz.2015.37 · Cited by 58
de Bartolomeis, A., & Tomasetti, C. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8293-6 · Cited by 65
Kristiansen, L. V., Bakir, B., Haroutunian, V., & Meador-Woodruff, J. H. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.02.1069 · Cited by 54
Self-citationVrajová, M., Šťastný, F., Horáček, J., Lochman, J., Šerý, O., Peková, Š., Klaschka, J., & Höschl, C. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0145-z · Cited by 63
Yuan, A., Veeranna, Sershen, H. W., Basavarajappa, B. S., Smiley, J. F., Hashim, A., Bleiwas, C., Berg, M. J., Guifoyle, D. N., Subbanna, S., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0194-7 · Cited by 56
Pakkenberg, B., Scheel‐Krüger, J., & Kristiansen, L. V. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01447.x · Cited by 53
Self-citationIasevoli, F., Tomasetti, C., Buonaguro, E. F., & de Bartolomeis, A. (2014) · Current Neuropharmacology · doi:10.2174/1570159x12666140324183406 · Cited by 58
Geddes, A. E., Huang, X., & Newell, K. A. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.02.017 · Cited by 64
Cheng, M.-C., Lu, C.-L., Luu, S.-U., Tsai, H.-M., Hsu, S.-H., Chen, T.-T., & Chen, C.-H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015107 · Cited by 59
De Novo Truncating Mutation in Kinesin 17 Associated with Schizophrenia
Tarabeux, J., Champagne, N., Brustein, E., Hamdan, F. F., Gauthier, J., Lapointe, M., Maios, C., Piton, A., Spiegelman, D., Henrion, É., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.018 · Cited by 56
Tucholski, J., Simmons, M. S., Pinner, A. L., McMillan, L. D., Haroutunian, V. H., & Meador‐Woodruff, J. H. (2013) · Neuroreport · doi:10.1097/wnr.0b013e328363bd8a · Cited by 54
Self-citationKnockdown of mental disorder susceptibility genes disrupts neuronal network physiology in vitro
MacLaren, E. J., Charlesworth, P., Coba, M. P., & Grant, S. G. N. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2010.12.014 · Cited by 60
NR1 knockdown mice as a representative model of the glutamate hypothesis of schizophrenia
Ramsey, A. J. (2009) · Progress in brain research · doi:10.1016/s0079-6123(09)17906-2 · Cited by 58
Kehr, J., Yoshitake, T., Ichinose, F., Yoshitake, S., Kiss, B., Gyertyán, I., & Adham, N. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4874-z · Cited by 50
Specific Roles of NMDA Receptor Subunits in Mental Disorders
Yamamoto, H., Hagino, Y., Kasai, S., & Ikeda, K. (2015) · Current Molecular Medicine · doi:10.2174/1566524015666150330142807 · Cited by 56
Matosin, N., Fernandez, F., Lum, J. S., & Newell, K. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.003 · Cited by 51
Schoonover, K. E., Dienel, S. J., & Lewis, D. A. (2020) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2020.100015 · Cited by 52
The kinesin superfamily protein KIF17: one protein with many functions
Wong‐Riley, M. T. T., & Besharse, J. C. (2012) · BioMolecular Concepts · doi:10.1515/bmc-2011-0064 · Cited by 51
Gene Expression Analysis Implicates a Death Receptor Pathway in Schizophrenia Pathology
Catts, V. S., & Shannon Weickert, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035511 · Cited by 43
Iasevoli, F., Fiore, G., Cicale, M., Muscettola, G., & de Bartolomeis, A. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.02.009 · Cited by 42
Dean, B., Karl, T., Pavey, G., Boer, S., Duffy, L., & Scarr, E. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.10.013 · Cited by 44
Wijtenburg, S. A., Wang, M., Korenic, S. A., Chen, S., Barker, P. B., & Rowland, L. M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.656459 · Cited by 42
Sun, Y., Cheng, X., Zhang, L., Hu, J. H., chen, Y., Zhan, L., & Gao, Z. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9715-7 · Cited by 43
Kindlundh-Högberg, A. M., Blomqvist, A., Malki, R., & Schiöth, H. B. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-39 · Cited by 40
Postsynaptic Density-95 Isoform Abnormalities in Schizophrenia
Funk, A. J., Mielnik, C. A., Koene, R., Newburn, E. N., Ramsey, A. J., Lipska, B. K., & McCullumsmith, R. E. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw173 · Cited by 41
Okubo, R., Okada, M., & Motomura, E. (2024) · Biomolecules · doi:10.3390/biom14091128 · Cited by 41
Peptide Sharing Between Influenza A H1N1 Hemagglutinin and Human Axon Guidance Proteins
Lucchese, G., Capone, G., & Kanduc, D. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs197 · Cited by 38
Jahn, K., Wieltsch, C., Blumer, N., Mehlich, M., Pathak, H., Khan, H. U., Hildebrandt, H., & Frieling, H. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1769-9 · Cited by 37
Metadata
- Authors
- Kristiansen, L. V., Beneyto, M., Haroutunian, V, & Meador-Woodruff, J. H.
- Affiliations
- University of Alabama at Birmingham (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Kristiansen, L V
- Venue
- Molecular Psychiatry
- Published
- 2006-05-16
- Volume
- 11
- Issue
- 8
- Pages
- 737-747
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W1969409914
- Cited by
- 220
- References
- 84
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 4 · 2023: 9 · 2022: 6 · 2021: 11 · 2020: 12 · 2019: 6 · 2018: 10 · 2017: 11 · 2016: 13 · 2015: 20 · 2014: 11 · 2013: 14 · 2012: 13
- FWCI
- 8.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01mh045212-05)
- National Institute of Mental Health (MH 53327, R01MH053327, MH 45212, R01MH064673, MH-064673)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- schizophrenia, NMDA receptor, NR2 subunits, postsynaptic density, dorsolateral prefrontal cortex, anterior cingulate cortex, PSD-95, PSD-93, SAP102, neurofilament light chain, alternative splicing, post-transcriptional regulation, protein stability, receptor trafficking
- MeSH terms
- Disks Large Homolog 4 Protein, Aged, Aged, 80 and over, Female, Gyrus Cinguli, Humans, Male, Membrane Proteins, Middle Aged, Nerve Tissue Proteins, Nuclear Proteins, Schizophrenia, Transcription Factors, Blotting, Western, Gene Expression, Receptors, N-Methyl-D-Aspartate, Neurofilament Proteins, Prefrontal Cortex, In Situ Hybridization, Tumor Suppressor Proteins, Intracellular Signaling Peptides and Proteins, Guanylate Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.